Pharma & Biotech

Shares of Monopar Therapeutics experienced a significant rally, propelled by encouraging clinical trial developments and a wave of positive analyst...

The biotechnology firm G1 Therapeutics has ceased to be a publicly traded entity following its successful acquisition by the Danish...

Vanda Pharmaceuticals Inc. (Vanda) provided a comprehensive update on its strategic direction and drug development pipeline during the Cantor Global...

Keros Therapeutics Inc (NASDAQ: KROS) is drawing significant market attention as CEO Jasbir Seehra prepares to present at the Wells...

Myriad Genetics has announced compelling new clinical evidence supporting its GeneSight Psychotropic test. A comprehensive meta-analysis released yesterday, which included...

QuidelOrtho shares closed Wednesday's session at $27.61, marking a decline of 2.27%. This downward movement occurred even as RBC Capital...

At the recent Wells Fargo Healthcare Conference, Vertex Pharmaceuticals CEO Reshma Kewalramani underscored the profound strategic importance of the company's...

Krystal Biotech finds itself at a critical juncture this week as market participants weigh recent operational successes against emerging challenges....

Danaher Corporation presents investors with a compelling puzzle. The global life sciences and diagnostics giant continues to deliver robust quarterly...

Assembly Biosciences continues to face significant headwinds in the equity markets, with its stock price locked in a persistent decline....